1-8 of 8
Yushe Dang
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Phase I/II Trial of HER2 Vaccine–Primed Autologous T-Cell Infusions in Patients with Treatment Refractory HER2–Overexpressing Breast Cancer

Mary L. Disis, Yushe Dang, Andrew L. Coveler, Jennifer S. Childs, Doreen M. Higgins, Ying Liu, Jing Zhou, Sean Mackay, Lupe G. Salazar
Journal: Clinical Cancer Research
Clin Cancer Res (2023) 29 (17): 3362–3371.
https://doi.org/10.1158/1078-0432.CCR-22-3578
Published: 01 September 2023
View articletitled, A Phase I/II Trial of HER2 Vaccine–Primed Autologous T-Cell Infusions in Patients with Treatment Refractory HER2–Overexpressing Breast Cancer
Open the PDF for A Phase I/II Trial of HER2 Vaccine–Primed Autologous T-Cell Infusions in Patients with Treatment Refractory HER2–Overexpressing Breast Cancer in another window
Includes: Supplementary data
Journal Articles

Immunization with a Plasmid DNA Vaccine Encoding the N-Terminus of Insulin-like Growth Factor Binding Protein-2 in Advanced Ovarian Cancer Leads to High-level Type I Immune Responses

Denise L. Cecil, John B. Liao, Yushe Dang, Andrew L. Coveler, Angela Kask, Yi Yang, Jennifer S. Childs, Doreen M. Higgins, Mary L. Disis
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (23): 6405–6412.
https://doi.org/10.1158/1078-0432.CCR-21-1579
Published: 01 December 2021
View articletitled, Immunization with a Plasmid DNA Vaccine Encoding the N-Terminus of Insulin-like Growth Factor Binding Protein-2 in Advanced Ovarian Cancer Leads to High-level Type I Immune Responses
Open the PDF for Immunization with a Plasmid DNA Vaccine Encoding the N-Terminus of Insulin-like Growth Factor Binding Protein-2 in Advanced Ovarian Cancer Leads to High-level Type I Immune Responses in another window
Includes: Supplementary data
Journal Articles

Immunization against HIF-1α Inhibits the Growth of Basal Mammary Tumors and Targets Mammary Stem Cells In Vivo

Denise L. Cecil, Meredith Slota, Megan M. O'Meara, Benjamin C. Curtis, Ekram Gad, Yushe Dang, Daniel Herendeen, Lauren Rastetter, Mary L. Disis
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (13): 3396–3404.
https://doi.org/10.1158/1078-0432.CCR-16-1678
Published: 02 July 2017
View articletitled, Immunization against HIF-1α Inhibits the Growth of Basal Mammary Tumors and Targets Mammary Stem Cells In Vivo
Open the PDF for Immunization against HIF-1α Inhibits the Growth of Basal Mammary Tumors and Targets Mammary Stem Cells In Vivo in another window
Includes: Supplementary data
Journal Articles

Abstract NTOC-097: VACCINATION TARGETING INSULIN–LIKE GROWTH FACTOR BINDING PROTEIN–2 (IGFBP–2) IN ADVANCED OVARIAN CANCER: SAFETY, IMMUNOGENICITY, AND SURVEILLANCE, EPIDEMIOLOGY, AND END RESULTS (SEER) COMPARISON

John B. Liao, Denise L. Cecil, Yushe Dang, Kelsey K. Baker, Kelsie J. Ovenell, Jessica Reichow, Stephanie Parker, Doreen M. Higgins, Jennifer S. Childs, Elizabeth K. Broussard, Andrew L. Coveler, Lupe G. Salazar, Barbara A. Goff, Mary W. Redman, Mary L. Disis
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (11_Supplement): NTOC-097.
https://doi.org/10.1158/1557-3265.OVCASYMP16-NTOC-097
Published: 31 May 2017
View articletitled, Abstract NTOC-097: VACCINATION TARGETING INSULIN–LIKE GROWTH FACTOR BINDING PROTEIN–2 (IGFBP–2) IN ADVANCED OVARIAN CANCER: SAFETY, IMMUNOGENICITY, AND SURVEILLANCE, EPIDEMIOLOGY, AND END RESULTS (SEER) COMPARISON
Journal Articles

The Antitumor Efficacy of IL2/IL21-Cultured Polyfunctional Neu-Specific T Cells Is TNFα/IL17 Dependent

Vy Phan-Lai, Yushe Dang, Ekram Gad, Jennifer Childs, Mary L. Disis
Journal: Clinical Cancer Research
Clin Cancer Res (2016) 22 (9): 2207–2216.
https://doi.org/10.1158/1078-0432.CCR-15-2273
Published: 01 May 2016
View articletitled, The Antitumor Efficacy of IL2/IL21-Cultured Polyfunctional Neu-Specific T Cells Is TNFα/IL17 Dependent
Open the PDF for The Antitumor Efficacy of IL2/IL21-Cultured Polyfunctional Neu-Specific T Cells Is TNFα/IL17 Dependent in another window
Includes: Supplementary data
Journal Articles

Dendritic Cell–Activating Vaccine Adjuvants Differ in the Ability to Elicit Antitumor Immunity Due to an Adjuvant-Specific Induction of Immunosuppressive Cells

Yushe Dang, Wolfgang M. Wagner, Ekram Gad, Lauren Rastetter, Carmen M. Berger, Gregory E. Holt, Mary L. Disis
Journal: Clinical Cancer Research
Clin Cancer Res (2012) 18 (11): 3122–3131.
https://doi.org/10.1158/1078-0432.CCR-12-0113
Published: 31 May 2012
View articletitled, Dendritic Cell–Activating Vaccine Adjuvants Differ in the Ability to Elicit Antitumor Immunity Due to an Adjuvant-Specific Induction of Immunosuppressive Cells
Open the PDF for Dendritic Cell–Activating Vaccine Adjuvants Differ in the Ability to Elicit Antitumor Immunity Due to an Adjuvant-Specific Induction of Immunosuppressive Cells in another window
Includes: Supplementary data
Journal Articles

Polysaccharide Krestin Is a Novel TLR2 Agonist that Mediates Inhibition of Tumor Growth via Stimulation of CD8 T Cells and NK Cells

Hailing Lu, Yi Yang, Ekram Gad, Cynthia A. Wenner, Amy Chang, Emily R. Larson, Yushe Dang, Mark Martzen, Leanna J. Standish, Mary L. Disis
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (1): 67–76.
https://doi.org/10.1158/1078-0432.CCR-10-1763
Published: 04 January 2011
View articletitled, Polysaccharide Krestin Is a Novel TLR2 Agonist that Mediates Inhibition of Tumor Growth via Stimulation of CD8 T Cells and NK Cells
Open the PDF for Polysaccharide Krestin Is a Novel TLR2 Agonist that Mediates Inhibition of Tumor Growth via Stimulation of CD8 T Cells and NK Cells in another window
Includes: Supplementary data
Journal Articles

Tumor Antigen–Specific T-Cell Expansion Is Greatly Facilitated by In vivo Priming

Yushe Dang, Keith L. Knutson, Vivian Goodell, Corazon dela Rosa, Lupe G. Salazar, Doreen Higgins, Jennifer Childs, Mary L. Disis
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (6): 1883–1891.
https://doi.org/10.1158/1078-0432.CCR-06-2083
Published: 15 March 2007
View articletitled, Tumor Antigen–Specific T-Cell Expansion Is Greatly Facilitated by In vivo Priming
Open the PDF for Tumor Antigen–Specific T-Cell Expansion Is Greatly Facilitated by In vivo Priming in another window